| David Mierzwiak, MD | |
|
2801 Bay Park Dr, Oregon, OH 43616-4920 | |
| (419) 690-7900 | |
| Not Available |
| Full Name | David Mierzwiak |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2801 Bay Park Dr, Oregon, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437151115 | NPI | - | NPPES |
| 0720867 | Medicaid | OH | |
| 000000246968 | Other | OH | ANTHEM |
| 000000550248 | Other | OH | ANTHEM BLUE CROSS BLUE SHIELD |
| 4488832 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 35056910 (Ohio) | Primary |
| Entity Name | Emergency Physicians Of Northwest Ohio, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043274418 PECOS PAC ID: 3375456478 Enrollment ID: O20031106000006 |
News Archive
The Associated Press: "The new health care law already is helping millions of people through tax breaks for small businesses and assistance for families with young adults, President Barack Obama said Saturday" (Babington, 5/8).
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
Investigators at Rutgers Cancer Institute of New Jersey have found that a treatment based on a novel cellular product programmed to deliver an overabundance of chimeric antigen receptor causes cell death in non-Hodgkin lymphoma models that are sensitive or resistant to standard therapies.
Advances in endoscopic technologies and techniques will be highlighted in clinical research presented at the 77th Annual Scientific Meeting of the American College of Gastroenterology in Las Vegas, NV.
› Verified 1 days ago
| Entity Name | Omni Health Services, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932380086 PECOS PAC ID: 2961584610 Enrollment ID: O20080204000037 |
News Archive
The Associated Press: "The new health care law already is helping millions of people through tax breaks for small businesses and assistance for families with young adults, President Barack Obama said Saturday" (Babington, 5/8).
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
Investigators at Rutgers Cancer Institute of New Jersey have found that a treatment based on a novel cellular product programmed to deliver an overabundance of chimeric antigen receptor causes cell death in non-Hodgkin lymphoma models that are sensitive or resistant to standard therapies.
Advances in endoscopic technologies and techniques will be highlighted in clinical research presented at the 77th Annual Scientific Meeting of the American College of Gastroenterology in Las Vegas, NV.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Mierzwiak, MD Po Box 633390, Cincinnati, OH 45263-3390 Ph: (800) 594-1876 | David Mierzwiak, MD 2801 Bay Park Dr, Oregon, OH 43616-4920 Ph: (419) 690-7900 |
News Archive
The Associated Press: "The new health care law already is helping millions of people through tax breaks for small businesses and assistance for families with young adults, President Barack Obama said Saturday" (Babington, 5/8).
iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces its featured products at the European Society of Radiology's annual meeting being held in Vienna, Austria from March 3 - 7, 2011.
Investigators at Rutgers Cancer Institute of New Jersey have found that a treatment based on a novel cellular product programmed to deliver an overabundance of chimeric antigen receptor causes cell death in non-Hodgkin lymphoma models that are sensitive or resistant to standard therapies.
Advances in endoscopic technologies and techniques will be highlighted in clinical research presented at the 77th Annual Scientific Meeting of the American College of Gastroenterology in Las Vegas, NV.
› Verified 1 days ago
Mark Sniadanko, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Navarre Ave, Oregon, OH 43616 Phone: 419-696-7500 | |
Erica Pribis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2801 Bay Park Dr, Oregon, OH 43616 Phone: 419-690-7900 | |
Dr. Melissa K Amonette, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Navarre Avenue, Oregon, OH 43616 Phone: 419-696-7300 | |
Josh Bohn, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3225 Pickle Rd, Oregon, OH 43616 Phone: 419-693-0465 | |
Paul Walker, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2801 Bay Park Dr, Oregon, OH 43616 Phone: 419-690-7900 | |
Wendelin Kreifels, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Navarre Ave, Oregon, OH 43616 Phone: 419-696-7411 | |
Lynn T Mason, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2600 Navarre Ave, Oregon, OH 43616 Phone: 419-696-7411 |